Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement

Nestlé

Status: Completed

Conditions: Healthy Subjects

Treatments: Other: Oral Nutrition Supplement

Study type: Interventional

Funder types: Industry

Identifiers

NCT02717234

14.31.US.CLI

Details and patient eligibility

About

To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake

Enrollment: 12 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer)
• Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing
• Willing to provide signed informed consent

Exclusion criteria

• Smoker
• Patients with potential for non-compliance
• Patients with allergy to ingredients in test products (i.e. milk protein, fish oil)
• Subject who in the Investigator's assessment cannot be expected to comply with study protocol
• Currently participating in another conflicting clinical trial.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

12 participants in 2 patient groups

Impact Advanced Recovery

Active Comparator group

Description:

Oral nutrition supplement intended for consumption at 3 servings per day

Treatment:

Other: Oral Nutrition Supplement

Impact Advanced Recovery-R

Experimental group

Description:

Oral nutrition supplement intended for consumption at 3 servings per day

Treatment:

Other: Oral Nutrition Supplement